Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

104 Results
Author: personID (integer) : 890662
Image document

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus

David Durantel , Sandra Carrouée-Durantel , Bettina Werle-Lapostolle , Marie-Noëlle Brunelle , Christian Pichoud , et al.
Hepatology, 2004, 40 (4), pp.855-864
Journal articles inserm-00137151v1
Image document

Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient.

Stéphanie Villet , Aurélie Ollivet , Christian Pichoud , Luc Barraud , Jean-Pierre Villeneuve , et al.
Journal of Hepatology, 2007, 46 (3), pp.531-8. ⟨10.1016/j.jhep.2006.11.016⟩
Journal articles inserm-00133115v1
Image document

Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

Fabien Zoulim , Maria Buti , Anna Lok
Journal of Viral Hepatitis, 2007, 14 Suppl 1, pp.29-36. ⟨10.1111/j.1365-2893.2007.00915.x⟩
Journal articles inserm-00193662v1
Image document

Drug-resistant and immune-escape HBV mutants in HIV-infected hosts.

Karine Lacombe , Anders Boyd , Joël Gozlan , Fabien Lavocat , Pierre-Marie Girard , et al.
Antiviral Therapy, 2010, 15 (3 Pt B), pp.493-7. ⟨10.3851/IMP1495⟩
Journal articles inserm-00491989v1
Image document

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa

Anders Boyd , Sarah Maylin , Raoul Moh , Nadia Mahjoub , Delphine Gabillard , et al.
Journal of Gastroenterology and Hepatology, 2016, 31 (3), pp.634-644. ⟨10.1111/jgh.13156⟩
Journal articles hal-01288716v1

Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B

Margarita Papatheodoridi , Emilia Hadziyannis , Françoise Berby , Kalliopi Zachou , Barbara Testoni , et al.
Journal of Viral Hepatitis, 2019, 27 (2), pp.118-126. ⟨10.1111/jvh.13211⟩
Journal articles hal-03932525v1
Image document

Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies

Nathalie Isorce , Julie Lucifora , Fabien Zoulim , David Durantel
Antiviral Research, 2015, 122, pp.69 - 81. ⟨10.1016/j.antiviral.2015.08.008⟩
Journal articles hal-03319419v1
Image document

Early inhibition of hepatocyte innate responses by hepatitis B virus

Souphalone Luangsay , Marion Gruffaz , Nathalie Isorce , Barbara Testoni , Maud Michelet , et al.
Journal of Hepatology, 2015, 63 (6), pp.1314-1322. ⟨10.1016/j.jhep.2015.07.014⟩
Journal articles hal-03315640v1

Biological basis for functional cure of chronic hepatitis B

Maria Martinez , Barbara Testoni , Fabien Zoulim
Journal of Viral Hepatitis, 2019, 26 (7), pp.786-794. ⟨10.1111/jvh.13090⟩
Journal articles hal-03932283v1
Image document

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

Julie Lucifora , Marc Bonnin , Ludovic Aillot , Floriane Fusil , Sarah Maadadi , et al.
Scientific Reports, 2018, 8 (1), pp.5390. ⟨10.1038/s41598-018-23525-w⟩
Journal articles hal-01953649v1

Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle

Thomas Lahlali , Jan Martin Berke , Karen Vergauwen , Adrien Foca , Koen Vandyck , et al.
Antimicrobial Agents and Chemotherapy, 2018, 62 (10), ⟨10.1128/AAC.00835-18⟩
Journal articles hal-04165602v1
Image document

External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV

Thierry Poynard , Jean Marc Lacombe , Olivier Deckmyn , Valentina Peta , Sepideh Akhavan , et al.
JHEP Reports Innovation in Hepatology, 2021, 3 (4), pp.100298. ⟨10.1016/j.jhepr.2021.100298⟩
Journal articles hal-03266490v1
Image document

Sofosbuvir-Daclatasvir Is Suboptimal in Patients with Genotype 2 Chronic Hepatitis C Infection: Real-life Experience from the HEPATHER ANRS CO22 Cohort

Victor Lédinghen , Clovis Lusivika-Nzinga , Jean-Pierre Bronowicki , Fabien Zoulim , Dominique Larrey , et al.
Journal of Viral Hepatitis, 2020, 27 (10), pp.964--973. ⟨10.1111/jvh.13321⟩
Journal articles hal-03704126v1
Image document

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Christophe Hézode , Hélène Fontaine , Céline Dorival , Fabien Zoulim , Dominique Larrey , et al.
Gastroenterology, 2014, 147 (1), pp.132-142.e4. ⟨10.1053/j.gastro.2014.03.051⟩
Journal articles inserm-01057763v1
Image document

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

Christophe Hezode , Pascal Lebray , Victor de Ledinghen , Fabien Zoulim , Vincent Di Martino , et al.
Liver International, 2017, 37 (9), pp.1314 - 1324. ⟨10.1111/liv.13383⟩
Journal articles hal-01784615v1
Image document

New anti-HCV agents in the pipeline

Fabien Zoulim
BMC Infectious Diseases, 2014, 14 (Suppl 2), pp.S15
Journal articles inserm-00995744v1
Image document

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Victor Virlogeux , Fabien Zoulim , Pascal Pugliese , Isabelle Poizot-Martin , Marc-Antoine Valantin , et al.
BMC Medicine, 2017, 15 (1), pp.217. ⟨10.1186/s12916-017-0979-1⟩
Journal articles inserm-01685739v1

How to improve access to therapy in hepatitis B patients

Miroslava Subic , Fabien Zoulim
Liver International, 2018, 38, pp.115-121. ⟨10.1111/liv.13640⟩
Journal articles hal-04165546v1

Late hepatitis B reactivation following direct‐acting antiviral–based treatment of recurrent hepatitis C in an anti‐HBc–positive liver transplant recipient

Julien Vionnet , Manuel Pascual , Barbara Testoni , Christophe Combet , Sébastien Godat , et al.
Hepatology, 2018, 67 (2), pp.791-793. ⟨10.1002/hep.29528⟩
Journal articles hal-04165532v1
Image document

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation

Paolo Angelo Cortesi , Raffaella Viganò , Sara Conti , Ilaria Lenci , Riccardo Volpes , et al.
Transplant International, 2023, 36, pp.10954. ⟨10.3389/ti.2023.10954⟩
Journal articles hal-04165716v1
Image document

Emerging drugs for hepatitis B.

Fabien Zoulim
Expert Opinion on Emerging Drugs, 2007, 12 (2), pp.199-217. ⟨10.1517/14728214.12.2.199⟩
Journal articles inserm-00162225v1

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

Matias Avila , Jean-François Dufour , Alexander Gerbes , Fabien Zoulim , Ramon Bataller , et al.
Gut, 2020, 69 (4), pp.764-780. ⟨10.1136/gutjnl-2019-319720⟩
Journal articles hal-03932559v1

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

Anna Lok , Fabien Zoulim , Geoffrey Dusheiko , Henry L.Y. Chan , Maria Buti , et al.
Hepatology Communications, 2019, 4 (1), pp.8-20. ⟨10.1002/hep4.1436⟩
Journal articles hal-03932571v1

Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus\textendashHepatitis B Virus Co-infected Patients from Sub-Saharan Africa

Anders Boyd , Laura Houghtaling , Raoul Moh , Mariama Abdou Chekaraou , Delphine Gabillard , et al.
The American Journal of Tropical Medicine and Hygiene, 2017, 97 (6), pp.1936--1942. ⟨10.4269/ajtmh.16-1016⟩
Journal articles hal-03704124v1
Image document

Inducers of NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro

Maud Michelet , Dulce Alfaiate , Brieux Chardès , Caroline Pons , Suzanne Faure-Dupuy , et al.
JHEP Reports Innovation in Hepatology, 2021, pp.100415. ⟨10.1016/j.jhepr.2021.100415⟩
Journal articles hal-03520759v1
Image document

Hepatitis B virus genetic variability and evolution.

Alan Kay , Fabien Zoulim
Virus Research, 2007, 127 (2), pp.164-76. ⟨10.1016/j.virusres.2007.02.021⟩
Journal articles inserm-00133137v1
Image document

A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine

Fabien Zoulim , Thierry Poynard , Françoise Degos , Alain Slama , Abdelkhader Al Hasnaoui , et al.
Journal of Viral Hepatitis, 2006, 13 (4), pp.278-288
Journal articles inserm-00135954v1
Image document

Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure

Marianne Maynard , Parviz Parvaz , Sandra Durantel , Michèle Chevallier , Philippe Chevallier , et al.
Journal of Hepatology, 2005, 42 (2), pp.279-81
Journal articles inserm-00135957v1
Image document

Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.

Olivier Diaz , François Delers , Marianne Maynard , Sylvie Demignot , Fabien Zoulim , et al.
J Gen Virol, 2006, 87 (Pt 10), pp.2983-91. ⟨10.1099/vir.0.82033-0⟩
Journal articles inserm-00139590v1
Image document

Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection

Caroline Aspord , Juliana Bruder Costa , Marie-Christine Jacob , Tania Dufeu-Duchesne , Inga Bertucci , et al.
PLoS ONE, 2016, 11 (6), pp.e0156200. ⟨10.1371/journal.pone.0156200⟩
Journal articles hal-01332410v1